Key Specialized Monitoring of Clinical Safety of Pudilan Xiaoyan Oral Liquid in the Real World

China Academy of Chinese Medical Sciences

Status: Unknown

Conditions: Respiratory Infectious Diseases

Treatments: Drug: Pudilan Xiaoyan Oral Liquid

Study type: Observational

Funder types: Other

Identifiers

NCT04031651

PUDILAN

Details and patient eligibility

About

To obtain the characteristics of adverse reactions/incidents, analyze the influencing factors and calculate the incidence of adverse reactions/incidents monitored by Pudilan Xiaoyan Oral Liquid in key specialties in the real world, so as to provide a basis for clinical safe and rational drug use.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• (1)Upper respiratory tract infection patients using Pudilan antiphlogistic oral liquid ;
• (2)Aged between 18 and 80.

Exclusion criteria

• Lactating women, pregnant women, pregnant planners, psychiatric patients, etc.